ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,297.60
      0.00%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      73.80
      -0.12%
      Bitcoin
      63,418.21
      -0.32%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Brainstorm Cell Therapeutics Inc (BCLI)

      7. Brainstorm Cell Therapeutics Inc (BCLI) News

      BCLI

      Brainstorm Cell Therapeu... (BCLI)

      Brainstorm Cell Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BCLI
      DateTimeSourceHeadlineSymbolCompany
      09/17/20243:32PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      09/16/20244:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      09/09/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/28/20245:01PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/16/20247:03AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/16/20247:00AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/14/20248:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/14/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/06/20244:59PMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      08/05/20245:11PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:09PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:08PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:07PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:07PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:06PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:06PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/31/20244:05PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/30/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/24/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/24/20248:30AMPR Newswire (US)BCLI Update - Progress Supports Our 10x Plus Value Range PotentialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/24/20248:30AMPR Newswire (Canada)BCLI Update - Progress Supports Our 10x Plus Value Range PotentialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      07/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      06/14/202412:01PMPR Newswire (US)BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness ExpectationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      06/14/202412:01PMPR Newswire (Canada)BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness ExpectationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      06/04/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      06/03/20249:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      05/23/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      05/14/20245:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      05/14/20247:53AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
      05/07/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:BCLI